Performance of SN Smith & Nephew PLC | -21.2% in 12m

Compare SN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Smith & Nephew PLC with its related Sector/Index XLV

Compare Smith & Nephew PLC with its related Sector/Index XLV

Performance Duell SN vs XLV

TimeFrame SN XLV
1 Day 0.92% -0.07%
1 Week 2.20% 0.40%
1 Month 1.17% -2.57%
3 Months -8.12% -0.71%
6 Months 4.77% 11.70%
12 Months -21.2% 6.84%
YTD -5.58% 1.59%
Rel. Perf. 1m 0.30
Rel. Perf. 3m -1.10
Rel. Perf. 6m -0.23
Rel. Perf. 12m -3.02

Is Smith & Nephew PLC a good stock to buy?

Partly, yes. Based on ValueRay Fundamental Analyses, Smith & Nephew PLC (LSE:SN) is currently (May 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.54 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SN as of May 2024 is 852.25. This means that SN is currently overvalued and has a potential downside of -13.53% (Sold with Premium).

Is SN a buy, sell or hold?

Smith & Nephew PLC has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -21.18%.

In compare to Health Care Sector SPDR Fund, SN made -28.02% less over the last 12 months. Due to the underperformance, it is recommend to sell SN.
Values above 0%: SN is performing better - Values below 0%: SN is underperforming

Compare SN with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 1.89% 3.83% -13.31% -45.89%
US NASDAQ 100 QQQ 1.62% 4.39% -13.14% -55.74%
US Dow Jones Industrial 30 DIA 1.86% 3.52% -9.24% -36.84%
German DAX 40 DBXD 2.39% 3.45% -13.08% -34.32%
UK FTSE 100 ISFU 0.92% -1.55% -9.78% -30.73%
Shanghai Shenzhen CSI 300 CSI 300 -2.73% -2.18% 0.14% -11.23%
Hongkong Hang Seng HSI -4.67% -5.03% 4.27% -6.71%
Japan Nikkei 225 EXX7 -0.16% 6.53% -9.10% -40.98%
India NIFTY 50 INDA 0.88% -1.56% -16.11% -50.46%
Brasil Bovespa EWZ -0.95% 1.89% 0.44% -44.56%

SN Smith & Nephew PLC vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.39% 4.57% -15.13% -57.47%
Consumer Discretionary XLY 0.83% 2.90% -7.52% -42.70%
Consumer Staples XLP 2.33% 0.79% -7.05% -21.92%
Energy XLE 6.41% 5.19% -2.82% -40.12%
Financial XLF 3.23% 4.07% -17.64% -48.56%
Health Care XLV 1.80% 3.74% -6.93% -28.02%
Industrial XLI 2.64% 3.17% -17.33% -45.78%
Materials XLB 2.58% 5.18% -10.70% -34.63%
Real Estate XLRE 1.38% 5.54% -4.19% -24.66%
Technology XLK 2.47% 5.90% -11.59% -54.06%
Utilities XLU 0.78% -2.67% -7.55% -24.03%
Aerospace & Defense XAR -0.63% 0.15% -10.98% -42.26%
Biotech XBI -5.24% 3.75% -24.67% -32.00%
Homebuilder XHB 1.17% 5.18% -32.99% -69.68%
Retail XRT 1.81% 6.10% -16.18% -42.19%

SN Smith & Nephew PLC vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 7.81% 7.19% 5.10% -41.61%
Natural Gas UNG -1.21% 5.18% 53.81% 21.58%
Gold GLD 3.49% 0.11% -10.99% -34.84%
Silver SLV 4.99% -1.01% -11.95% -25.51%
Copper CPER 3.50% -8.50% -17.23% -39.27%

Returns of SN vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.52% 4.20% 0.56% -8.52%
iShares High Yield Corp. Bond HYG 1.17% 0.81% -2.62% -30.48%
Does Smith & Nephew PLC outperform its market, is SN a Sector Leader?
No, over the last 12 months Smith & Nephew PLC (SN) made -21.18%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months SN made -8.12%, while XLV made -0.71%.
Period SN XLV S&P 500
1 Month 1.17% -2.57% -2.66%
3 Months -8.12% -0.71% 2.48%
12 Months -21.18% 6.84% 24.71%